ALEXANDRIA, Va., Nov. 6 -- United States Patent no. 12,460,002, issued on Nov. 4, was assigned to Merus N.V. (Utrecht, Netherlands).
"CD3 binding molecules" was invented by Pieter Fokko Van Loo (Utrecht, Netherlands).
According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to heavy chain variable regions, binding domains and antibodies specific for human CD3, and CD3 binding proteins. The invention further relates to the use of a CD3 binding protein, preferably an antibody, of the invention in the treatment of cancer or autoimmune disease."
The patent was filed on March 27, 2020, under Application No. 17/438,768.
*For further information, including images, charts and tables, please visit: http:/...